Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Nearly 1 in 5 patients with dermatitis test positive for gold allergy, with women and those over 40 most affected. But a new Danish study brings reassuring news: a positive gold patch test doesn't signal a higher risk for autoimmune disease. Clinicians should not use it as a risk marker for autoimmune comorbidity.
Gold allergy is more common than you might think — especially among dermatitis patients. A large retrospective study out of Denmark found that nearly 1 in 5 patients with dermatitis (18.7%) tested positive for gold allergy via patch testing. Women were more than twice as likely to test positive as men, and patients over 40 also showed higher rates.
Despite its prevalence, the study offers a key reassurance: testing positive for gold allergy does not increase the risk of developing autoimmune disease. After analyzing data from over 3,400 patients and cross-referencing with Denmark's national patient registry, researchers found no significant association between gold allergy and any of the six autoimmune disease categories examined — dermatologic, endocrine, gastrointestinal-hepatic, rheumatologic, neurologic, or hematologic.
One notable finding: patients with stronger gold reactions were more likely to also be allergic to other metals like nickel, chromium, or cobalt, suggesting a pattern of multi-metal sensitization.
Key Takeaways:
Why it matters: For dermatologists and allergists, this study clarifies that while gold allergy is worth diagnosing and managing, it doesn't warrant additional autoimmune disease workup — helping avoid unnecessary testing and patient anxiety.
